AC Immune (ACIU) Receivables - Other (2015 - 2025)

AC Immune (ACIU) has 11 years of Receivables - Other data on file, last reported at $1.2 million in Q4 2025.

• Quarterly Receivables - Other fell 2.9% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 2.9% YoY) and the FY2025 annual result came in at $1.2 million, down 6.4% from the prior year.
• Receivables - Other declined to $1.2 million in Q4 2025 per ACIU's latest filing, from $2.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $701.2 million in Q4 2023 and bottomed at $288027.0 in Q1 2022.
• The 5-year median for Receivables - Other is $1.3 million (2024), against an average of $114.2 million.
• The widest annual swing landed in 2022, when Receivables - Other sank 99.93%; it then surged 172228.97% in 2023.
• Tracing ACIU's Receivables - Other over 5 years: stood at $464.2 million in 2021, then slumped by 99.91% to $406904.6 in 2022, then surged by 172228.97% to $701.2 million in 2023, then slumped by 99.82% to $1.3 million in 2024, then slipped by 2.9% to $1.2 million in 2025.
• Per Business Quant, the three latest ACIU Receivables - Other figures stand at $1.2 million (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025).

Peer Comparison